2022 CNS Research Day

Event Header image

On Tuesday, May 17th 2022, the Department of Clinical Neurological Sciences will be hosting its 19th annual CNS Research Day. The full day event features a series of poster and oral presentations from our residents, graduate students, PhD candidates and postdoctoral fellows. We will also host a distinguished researcher who will present the keynote address. Attendees of the event are the Department’s faculty, including neurosurgeons, neurologists, affiliated radiologists, pathologists and imaging researchers.

Congratulations to the 2022 Award Winners!

Click here to see the 2022 CNS Research Day event photos!

Event Program

Download your copy of the event program here.

Venue

King's University College

266 Epworth Avenue, London, ON N6A 2M3

CNS Research Day will be held at the Kings Centre (Main level map, Lower level map).

Free parking is available. The closest parking lot is P3 (map).

Schedule of Events

View the PDF version of the agenda here.

8:00-8:15 a.m. Registration and Continental Breakfast Garron/Spriet Lounge
8:20-8:30 a.m. Opening Remarks
Dr. David Steven, Richard and Beryl Ivey Chair, Department of Clinical Neurological Sciences
Kenny Theatre
8:35-9:30 a.m. Oral Presentation Session #1
A series of 5-minute presentations. Each presenter will be allotted 3 minutes for questions.
PLAT-1 to PLAT-6
Kenny Theatre
9:30-9:40 a.m. Refreshment Break Garron/Spriet Lounge
9:40-10:15 a.m. Oral Parallel Poster Session #1
A series of 2-minute presentations.
Q&A will commence during refreshment break
POST-1 to POST-17
Basement Classrooms
KC 005 & KC 006
10:15-10:40 a.m. Refreshment Break (continued)
Poster presentation Q&A
10:45-11:40 a.m. Oral Presentation Session #2
A series of 5-minute presentations. Each presenter will be allotted 3 minutes for questions.
PLAT-7 to PLAT-12
Kenny Theatre
11:45 a.m. - 12:40 p.m. LUNCH Garron/Spriet Lounge
12:45-1:40 p.m. Oral presentation Session #3
A series of 5-minute presentations. Each presenter will be allotted 3 minutes for questions.
PLAT-13 to PLAT-17
Kenny Theatre
1:50-2:20 p.m. Oral Parallel Poster Session #2
A series of 2-minute presentations.
Q&A will commence during refreshment break.
POST-18 to POST-29
Basement Classrooms
KC 005 & KC 006
2:20-2:40 p.m. Refreshment Break
Poster presentation Q&A
Garron/Spriet Lounge
2:45-3:40 p.m. Keynote Presentation
In the Mind’s Eye” Molecular Imaging Insights into Parkinson’s Disease
Dr. A. Jon Stoessl
Kenny Theatre
3:40-4:00 p.m. Closing Remarks and Awards
Dr. Elizabeth Finger, Research Director, Department of Clinical Neurological Sciences
Kenny Theatre

 

Attendee Registration

If you would like to attend this year's event, please register at the link here.https://uwo.eu.qualtrics.com/jfe/form/SV_agBWecGNKbofyZM

Registration Deadline: Monday, April 25th

Keynote Speaker

Stoessl---160x180.pngA. Jon Stoessl is Professor & Head of Neurology at UBC. He was previously Director of the Pacific Parkinson’s Research Centre, Co-Director, then Director of the Djavad Mowafaghian Centre for Brain Health. He held a Tier 1 Canada Research Chair in Parkinson’s and is Editor-in-Chief of Movement Disorders. He has served on numerous other editorial boards including Lancet Neurology and Annals of Neurology. He has previously chaired the Scientific Advisory Boards of Parkinson’s Canada and the Parkinson’s Foundation and is Past-President of the World Parkinson Coalition. He is a Member of the Order of Canada. Dr. Stoessl uses positron emission tomography to study Parkinson’s, including imaging biomarkers, the basis for complications of treatment and mechanisms of the placebo effect. He has published more than 300 papers and book chapters and has been cited more than 25,000 times in the scientific literature.

Judges

Andrade---160x180.pngDr. Andrea Andrade is a pediatric neurologist and epileptologist. She completed her medical degree and pediatric residency in Mexico City by the National University of Mexico. She subsequently completed a child neurology residency and epilepsy fellowship at University of Texas Southwestern in Dallas. Then moved to Canada where she completed further training in paediatric stroke and epilepsy surgery at University of Toronto, Sickkids Hospital. 

Currently Dr. Andrade leads the paediatric epilepsy program at Western and she is heavily involved on the Ontario Epilepsy taskforce and Project ECHO: Epilepsy across the life span. She also leads the Paediatric Stroke Program at Children's/LHSC and she is a member of the International Pediatric Stroke Study (IPSS) and a founding member of the International Paediatric Stroke Organization (IPSO). Her research interests are in paediatric epilepsy surgery, pharmaco-resistant epilepsies , paediatric stroke and implementation science areas where she has awarded multiple grants and published peer review articles and book chapters.

Pandey---160x180.pngDr. Sachin Pandey is an Associate Professor of Medical Imaging, at the University of Western Ontario, London, Ontario.  He is the Division Head for Diagnostic and Interventional Neuroradiology, the Co-Director of Charles Drake fellowship in Cerebrovascular and Endovascular Neurosurgery, and has Cross-Appointments in the Department of Clinical Neurosciences and Otorhinolaryngology. He serves as the Ontario Medical Association Section Chair for Neuroradiology; and has just completed his term as the President of the Professional Staff Organization, London Health Sciences Center.

Dr. Pandey attended medical school at Boston University School of Medicine, in Boston, MA, graduating in 2007.  He is a graduate of the Diagnostic Radiology Residency Program, Harvard University – Beth Israel Deaconess Medical Center; and continued on to a Fellowship in Interventional Neuroradiology, and Endovascular Neurosurgery at Harvard University, Brigham and Women’s Hospital and Boston Children’s Hospital.

He is deeply committed to education, and the training and mentoring of medical learners. He is the Director of Undergraduate Medical Education, in the Dept of Radiology; and the Education and Research director for the Diagnostic Neuroradiology Fellowship, University of Western Ontario Schulich School of Medicine. He serves as a Diagnostic Radiology Examiner, for the Royal College of Physicians and Surgeons (Canada). He has received multiple awards in recognition of his excellence in teaching, including the Harvard University Humanism Award and the Harvard University’s Andrew Berezin Award; as well as the Faculty Educator of the Year Award, and the Chair’s Award of Inspiration – Department of Medical Imaging, at University of Western Ontario.

Dr. Pandey lives in London, Ontario, with his wife, Charmi, and three bright, beautiful and talented daughters.

Stoessl---160x180.pngDr. A. Jon Stoessl is Professor & Head of Neurology at UBC. He was previously Director of the Pacific Parkinson’s Research Centre, Co-Director, then Director of the Djavad Mowafaghian Centre for Brain Health. He held a Tier 1 Canada Research Chair in Parkinson’s and is Editor-in-Chief of Movement Disorders. He has served on numerous other editorial boards including Lancet Neurology and Annals of Neurology. He has previously chaired the Scientific Advisory Boards of Parkinson’s Canada and the Parkinson’s Foundation and is Past-President of the World Parkinson Coalition. He is a Member of the Order of Canada. Dr. Stoessl uses positron emission tomography to study Parkinson’s, including imaging biomarkers, the basis for complications of treatment and mechanisms of the placebo effect. He has published more than 300 papers and book chapters and has been cited more than 25,000 times in the scientific literature.

Venance---160x180.pngDr. Shannon Venance, MD, PhD, FRCPC earned her PhD from Queen's University in 1993 and her MD from the University of Ottawa in 1997. Neurology residency training was completed at the University of Ottawa, followed by a Neuromuscular Fellowship at London Health Sciences Centre and muscle fellowship at the University of Rochester, NY.

Dr Venance joined the Department of Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, Western University in 2004 and was promoted to Associate Professor in 2010. Her clinical expertise is in disorders of muscle, and she collaborates with a diverse group of health professionals in the investigation and management of individuals with chronic muscle conditions.

Dr. Venance is a highly engaged clinician teacher, teaching and learning through the spectrum of undergraduate, postgraduate and continuing medical education. Most recently, she was appointed as the Vice Dean, Undergraduate Medical Education at the Schulich Medicine & Dentistry.  She works collaboratively to effect change in medical education with a focus on generalism within competency-based medical education models.

Important Dates

January 24th Abstract submissions open
March 10th Abstract submissions close
March 15th Abstract submissions distributed to Research Committee for scoring
April 1st Research Committee submits abstract scores
April 6th Research Committee selects abstracts for oral presentations, posters
April 10th Notification to presenters of oral/poster acceptance
May 17th Research Day!

Abstract Submission Guidelines

Submit Abstracts Here

Eligibility Requirements
Must have an author or contributor who holds a membership in CNS.
Abstracts should be no longer than 350 words and utilize the headings described below.
The presenter of all abstracts must be a trainee (for example, a undergraduate, graduate or medical student, resident, fellow).

Basic Information
Abstract Title, First Author, Additional Author(s) and Research Supervisor

Abstract Submission Criteria/Format
*based on the JAMA Structure for Abstract Submission

Importance:  

The abstract should begin with a maximum of two sentences explaining the clinical (or other) importance of the study question.

Objective(s): 

State the precise objective or study question addressed in the report (e.g. "To determine whether..."). If more than 1 objective is addressed, the main objective should be indicated and only key secondary objectives stated. If a priori hypothesis was tested, it should be stated.

Design and Participants:

Describe the basic design of the study and include the specific study type (e.g. randomized clinical trial, cohort, cross-sectional, etc.) and intervention where applicable. State the clinical disorders, important eligibility criteria, and key socio-demographic features of patients (or other study participants). The number of eligible participants and how they were selected should be provided, including the number approached but who refused or were excluded. For selection procedures, these terms should be used, if appropriate: random sample (where random refers to a formal, randomized selection in which all eligible individuals have a fixed and usually equal chance of selection); population-based sample; referred sample; consecutive sample; volunteer sample; convenience sample. If matching is used for comparison groups, characteristics that are matched should be specified. In follow-up studies, the proportion of participants who completed the study must be indicated.

Results:

Summary demographic information (e.g. characteristics such as sex and age) and the number of study participants should be reported in the first sentence of the Results paragraph. The main outcomes of the study should be reported and quantified, including the final included/analyzed sample. When possible, present numerical results (e.g. absolute numbers and/or rates) with appropriate indicators of uncertainty, such as confidence intervals. Use means and standard deviations (SDs) for normally distributed data and medians and ranges or interquartile ranges (IQRs) for data that are not normally distributed. Avoid solely reporting the results of statistical hypothesis testing, such as P values, which fail to convey important quantitative information. For most studies, P values should follow the reporting of comparisons of absolute numbers or rates and measures of uncertainty (e.g. 0.8%, 95% CI −0.2% to 1.8%; P = .13). 

Conclusions and Relevance:

Provide only conclusions of the study that are directly supported by the results. Give equal emphasis to positive and negative findings of equal scientific merit. Also, provide a statement of relevance indicating implications for clinical practice or health policy, avoiding speculation and overgeneralization. The relevance statement may also indicate whether additional study is required before the information should be used in clinical settings.

Click here to download this information as a PDF.

Resources

Poster Printing Services:

Abstract Writing Tips & Tricks:

Event Sponsors

Thank you to our 2022 Event Sponsors! UCB-Logo-Inspired-big.jpg

RocheLogo_PMS300.png

Award Winners

Visit our page after the event to see the 2022 Award Winners!

To view last year's winners, please visit the 2021 CNS Research Day page.